Fred
Chief development officer
oncology
KBP BioSciences
China
Biography
Fred leads development of medical strategies of the company. In this capacity Fred provides leadership and insights of medical development of the company’s clinical stage compounds. Fred has almost 20 years of experience in clinical research and drug development, with expertise focusing on statistics and quantitative science. He assumed increasing responsibilities in both Big Pharma (Abbott, Pharmacia, GSK etc.) and small biotech (Discovery Labs), overseeing biostatistics as well as trial conduct and strategic planning. He had successful end-to-end development and worldwide regulatory experiences. His therapeutic experiences range from diabetes, CV, arthritis, oncology and neonatal care, with many publications.
Research Interest
oncology